The DOI matches its Crossref record; 298 of the 298 references it cites were found in a registry or an index.
Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Open accessAbstract
During the past decade, a conceptual shift occurred in the field of Alzheimer's disease (AD) considering the disease as a continuum. Thanks to evolving biomarker research and substantial discoveries, it is now possible to identify the disease even at the preclinical stage before the occurrence of the first clinical symptoms. This preclinical stage of AD has become a major research focus as the field postulates that early intervention may offer the best chance of therapeutic success. To date, very little evidence is established on this “silent” stage of the disease. A clarification is needed about the definitions and lexicon, the limits, the natural history, the markers of progression, and the ethical consequence of detecting the disease at this asymptomatic stage. This article is aimed at addressing all the different issues by providing for each of them an updated review of the literature and evidence, with practical recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This could explain why part of the risk factors for cardiovascular disease are in common with AD, including hypertension, dyslipidemia, diabetes, obesity, dietary factors, smoking, and physical activity (Figure 1B).”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [22]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Thus, lifestyle is also an important risk factor, where intellectual, physical, and social activities, as well as diet, may help to prevent AD [1,22,100,101,102,103].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Thus, the disease is now regarded as a continuum rather than three distinct clinically defined entities [15].”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“While differences remain, IWG 2016 and the NIA research framework are aligned on the key issue that the combination of an abnormal Aβ and tau biomarker constitutes AD regardless of cognitive symptoms, and thus AD is a biologically defined entity throughout its continuum.”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [15]
In the citing paper
“Furthermore, drug development research for AD has become more complicated as preclinical and prodromal AD populations are potentially included in current trials, as well as traditionally included populations of all the clinical stages of AD dementia.38”
From Current and Future Treatments in Alzheimer Disease: An Update (2020) · cites this paper as [38]
In the citing paper
“Although the use of clinical trial simulators is not frequent in recent research,38”
From Current and Future Treatments in Alzheimer Disease: An Update (2020) · cites this paper as [38]
In the citing paper
“This asymptomatic phase of AD (AsymAD) is currently considered a preclinical stage of the disease [27, 28].”
From Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease (2018) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“From the tau protein perspective, one study showed that alterations in CSF levels of p-tau may precede those of Ab [57], which correlates with postmortem evidence showing the presence of neurofibrillary tangles in the entorhinal cortex and in hippocampal-related structures [58,59] as the first neuropathologic event in…”
ResultCorder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationBiomarkers and surrogate endpoints: Preferred definitions and conceptual framework
Biomarkers Definitions Working Group (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,771
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Exercise training increases size of hippocampus and improves memory
Erickson, K. I., Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L., Kim, J. S., Heo, S., Alves, H., White, S. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015950108 · Cited by 4,855
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Self-citationJack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Self-citationMeta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Self-citationClinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,003
de Haan, W., van Straaten, E. C. W., Gouw, A. A., & Stam, C. J. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005707 · Cited by 78
Self-citationCan exercise training teach us how to treat Alzheimer's disease?
Huuha, A. M., Norevik, C. S., Moreira, J. B. N., Kobro-Flatmoen, A., Scrimgeour, N., Kivipelto, M., Van Praag, H., Ziaei, M., Sando, S. B., Wisløff, U., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101559 · Cited by 79
Self-citationChételat, G. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179920 · Cited by 82
An overview of the genes and biomarkers in Alzheimer’s disease
Krishnamurthy, H. K., Jayaraman, V., Krishna, K., Wang, T., Bei, K., Changalath, C., & Rajasekaran, J. J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102599 · Cited by 89
Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer Dementia
Corso, G., Cristofano, A., Sapere, N., la Marca, G., Angiolillo, A., Vitale, M., Fratangelo, R., Lombardi, T., Porcile, C., Intrieri, M., et al. (2017) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000466688 · Cited by 81
Multiscale Neuroscience of Psychiatric Disorders
van den Heuvel, M. P., Scholtens, L. H., & Kahn, R. S. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.015 · Cited by 79
Ishaq, M., Taslımı, P., Shafiq, Z., Khan, S., Salmas, R. E., Zangeneh, M. M., Saeed, A., Zangeneh, A., Sadeghian, N., Asari, A., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103924 · Cited by 79
APOE-ε4 Carrier Status and Gut Microbiota Dysbiosis in Patients With Alzheimer Disease
Hou, M., Xu, G., Ran, M., Luo, W., & Wang, H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.619051 · Cited by 87
Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm
Grabowska, W., Want, A., Leszek, J., & Wojda, U. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103691 · Cited by 81
Frisoni, G. B., Molinuevo, J. L., Altomare, D., Carrera, E., Barkhof, F., Berkhof, J., Delrieu, J., Dubois, B., Kivipelto, M., Nordberg, A., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12132 · Cited by 78
Self-citationAltered gut microbiota in adults with subjective cognitive decline: the SILCODE study
Sheng, C., Lin, L., Lin, H., Wang, X., Han, Y., & Liu, S.-L. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210259 · Cited by 78
Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept
Epelbaum, S., Genthon, R., Cavedo, E., Habert, M. O., Lamari, F., Gagliardi, G. P., Lista, S., Teichmann, M., Bakardjian, H., Hampel, H. J., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.12.003 · Cited by 82
Self-citationExecutive function abilities in cognitively healthy young and older adults—A cross-sectional study
Idowu, M. I., & Szameitat, A. J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.976915 · Cited by 95
Antonell, A., Tort‐Merino, A., Ríos, J., Balasa, M., Borrego‐Écija, S., Auge, J. M., Muñoz‐García, C., Bosch, B., Falgàs, N., Rami, L., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.09.001 · Cited by 76
Self-citationNeuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease
Ng, K. P., Pascoal, T. A., Mathotaarachchi, S. S., Chung, C.-O., Benedet, A. L., Shin, M., Kang, M. S., Li, X., Ba, M., Kandiah, N., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003916 · Cited by 76
Self-citationBergen, J. M. G. V., Li, X., Quevenco, F. C., Gietl, A. F., Treyer, V., Meyer, R., Buck, A., Kaufmann, P. A., Nitsch, R. M., van Zijl, P. C. M., et al. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.03.021 · Cited by 77
The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease
Maestú, F., Cuesta, P., Hasan, O., Fernández, A., Funke, M. E., & Schulz, P. E. (2019) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2019.00017 · Cited by 78
microRNAs as early biomarkers of Alzheimer’s disease: a synaptic perspective
Siedlecki-Wullich, D., Miñano-Molina, A. J., & Rodríguez-Álvarez, J. (2021) · Cells · doi:10.3390/cells10010113 · Cited by 76
Lombardi, A., Diacono, D., Amoroso, N., Biecek, P., Monaco, A., Bellantuono, L., Pantaleo, E., Logroscino, G., Blasi, R. D., Tangaro, S., et al. (2022) · Brain Informatics · doi:10.1186/s40708-022-00165-5 · Cited by 82
Chatterjee, P., Goozee, K. G., Sohrabi, H. R., Shen, K., Shah, T. M., Asih, P. R., Dave, P., ManYan, C., Taddei, K., Chung, R. S., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180025 · Cited by 73
Self-citationYu, J., Li, J., Suckling, J., Feng, L., Pan, A., Wang, Y., Song, B., Zhu, S., Li, D., Wang, H.-F., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.05.006 · Cited by 72
Self-citationA Digital Twins Machine Learning Model for Forecasting Disease Progression in Stroke Patients
Allen, A. O., Siefkas, A. C., Pellegrini, E., Burdick, H., Barnes, G., Calvert, J. S., Mao, Q., & Das, R. (2021) · Applied Sciences · doi:10.3390/app11125576 · Cited by 78
Olesen, M. A., Villavicencio-Tejo, F., & Quintanilla, R. A. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00308-y · Cited by 80
Kenny, A., McArdle, H., Calero, M., Rábano, A., Madden, S. F., Adamson, K., Forster, R. J., Spain, E., Prehn, J. H. M., Henshall, D. C., et al. (2019) · Biomolecules · doi:10.3390/biom9110734 · Cited by 77
Więckowska‐Gacek, A., Mietelska‐Porowska, A., Chutorański, D., Wydrych, M., Długosz, J., & Wojda, U. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.654509 · Cited by 70
Valverde-Salazar, V., Ruiz-Gabarre, D., & García‐Escudero, V. (2023) · Antioxidants · doi:10.3390/antiox12071460 · Cited by 76
Mitochondrial RNA in Alzheimer’s Disease Circulating Extracellular Vesicles
Kim, K. M., Meng, Q., de Acha, O. P., Mustapić, M., Cheng, A., Eren, E., Kundu, G., Piao, Y., Munk, R. B., Wood, W. H., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.581882 · Cited by 72
Sibilano, E., Brunetti, A., Buongiorno, D., Lassi, M., Grippo, A., Bessi, V., Micera, S., Mazzoni, A., & Bevilacqua, V. (2023) · Journal of Neural Engineering · doi:10.1088/1741-2552/acb96e · Cited by 74
Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design
de Wilde, A., van Maurik, I. S., Kunneman, M., Bouwman, F. H., Zwan, M. D., Willemse, E. A. J., Biessels, G. J., Minkman, M. M. N., Pel‐Littel, R. E., Schoonenboom, N. S. M., et al. (2017) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.003 · Cited by 70
Self-citationPotential Utility of Retinal Imaging for Alzheimer’s Disease: A Review
Liao, H., Zhu, Z., & Peng, Y. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00188 · Cited by 68
Imaging and Molecular Mechanisms of Alzheimer’s Disease: A Review
Femminella, G. D., Thayanandan, T., Calsolaro, V., Komici, K., Rengo, G., Corbi, G., & Ferrara, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123702 · Cited by 74
Role of Executive Functions in the Conversion from Mild Cognitive Impairment to Dementia
Fernández, A. J., García-Zamora, E., Olazarán, J., Parra, M. A., & Fernández‐Guinea, S. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200586 · Cited by 69
A Multilevel View of the Development of Alzheimer’s Disease
Ávila, J., & Perry, G. L. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.11.015 · Cited by 69
RNA Dynamics in Alzheimer’s Disease
Rybak‐Wolf, A., & Plass, M. (2021) · Molecules · doi:10.3390/molecules26175113 · Cited by 72
Frailty Trajectories Preceding Dementia in the US and UK
Ward, D. D., Flint, J. P., Littlejohns, T. J., Foote, I. F., Canevelli, M., Wallace, L. M. K., Gordon, E. H., Llewellyn, D. J., Ranson, J. M., Hubbard, R. E., et al. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.3774 · Cited by 79
Challenges associated with biomarker‐based classification systems for Alzheimer's disease
Illán‐Gala, I., Pegueroles, J., Montal, V., Vilaplana, E., Carmona‐Iragui, M., Alcolea, D., Dickerson, B. C., Sánchez‐Valle, R., de Leon, M. J., Blesa, R., et al. (2018) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.03.004 · Cited by 62
Acute exercise does not modify brain activity and memory performance in APP/PS1 mice
Stein, A. M., Munive, V., Fernandez, A. M., Núñez, Á., & Torres‐Alemán, I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178247 · Cited by 68
Sugarman, M. A., Zetterberg, H., Blennow, K., Tripodis, Y., McKee, A. C., Stein, T. D., Martin, B. M., Palmisano, J. N., Steinberg, E. G., Simkin, I., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.05.011 · Cited by 68
Self-citationd’Abramo, C., D'adamio, L., & Giliberto, L. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030116 · Cited by 71
Considerations regarding a diagnosis of Alzheimer’s disease before dementia: a systematic review
van der Schaar, J., Visser, L. N. C., Bouwman, F. H., Ket, J. C. F., Scheltens, P., Bredenoord, A. L., & van der Flier, W. M. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00971-3 · Cited by 74
Self-citationBłaszczyk, J. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010543 · Cited by 74
Udeh-Momoh, C., & Watermeyer, T. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101459 · Cited by 67
Lichtenegger, A., Harper, D. J., Augustin, M., Eugui, P., Muck, M., Gesperger, J., Hitzenberger, C. K. F., Wöehrer, A., & Baumann, B. (2017) · Biomedical Optics Express · doi:10.1364/boe.8.004007 · Cited by 66
INSIGHT-AD study group, Habert, M., Bertin, H., Labit, M., Diallo, M., Marie, S., Martineau, K., Kas, A., Causse-Lemercier, V., Bakardjian, H., et al. (2017) · Annals of Nuclear Medicine · doi:10.1007/s12149-017-1221-0 · Cited by 67
Self-citationHameed, S., Fuh, J., Senanarong, V., Ebenezer, E. G. M., Looi, I., Dominguez, J. C., Park, K. W., Karanam, A. K., & Simon, O. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-190143 · Cited by 69
Jutten, R. J., Sikkes, S. A. M., Amariglio, R. E., Buckley, R. F., Properzi, M. J., Marshall, G. A., Rentz, D. M., Johnson, K. A., Teunissen, C. E., van Berckel, B. N. M., et al. (2020) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617720000934 · Cited by 71
Self-citationGenetic Variation in Targets of Antidiabetic Drugs and Alzheimer Disease Risk
Tang, B., Wang, Y., Jiang, X., Thambisetty, M., Ferrucci, L., Johnell, K., & Hägg, S. (2022) · Neurology · doi:10.1212/wnl.0000000000200771 · Cited by 68
Regional Precuneus Cortical Hyperexcitability in Alzheimer's Disease Patients
Casula, E. P., Borghi, I., Maiella, M., Pellicciari, M. C., Bonnı̀, S., Mencarelli, L., Assogna, M., D’Acunto, A., Lorenzo, F. D., Spampinato, D. A., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26514 · Cited by 70
Polygenic hazard scores in preclinical Alzheimer disease
Tan, C. H., Hyman, B. T., Tan, J. J. X., Hess, C. P., Dillon, W. P., Schellenberg, G. D., Besser, L. M., Kukull, W. A., Kauppi, K., McEvoy, L. K., et al. (2017) · Annals of Neurology · doi:10.1002/ana.25029 · Cited by 68
Marriott, R. J., Murray, K., Flicker, L. A., Hankey, G. J., Matsumoto, A. M., Dwivedi, G., Antonio, L., Almeida, O. P., Bhasin, S., Dobs, A. S., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12529 · Cited by 67
Cantero, J. L., Atienza, M., Lage, C., Záborszky, L., Vilaplana, E., López‐García, S., Pozueta, A., Rodríguez‐Rodríguez, E., Blesa, R., Alcolea, D. A., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz224 · Cited by 65
Cejnek, M., Vyšata, O., Vališ, M., & Bukovský, I. (2021) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-021-02427-6 · Cited by 68
Early brain connectivity alterations and cognitive impairment in a rat model of Alzheimer’s disease
Muñoz‐Moreno, E., Tudela, R., López-Gil, X., & Sòria, G. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0346-2 · Cited by 65
Goukasian, N., Hwang, K. S., Romero, T., Grotts, J., Do, T. M., Groh, J. R., Bateman, D. R., & Apostolova, L. G. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031947 · Cited by 64
de Wilde, A., van Buchem, M. M., Otten, R. H. J., Bouwman, F. H., Stephens, A. W., Barkhof, F., Scheltens, P., & van der Flier, W. M. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0398-3 · Cited by 65
Self-citationRifai, O. M., McGrory, S., Robbins, C. B., Grewal, D. S., Liu, A., Fekrat, S., & MacGillivray, T. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12149 · Cited by 63
Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease
Chen, S.-D., Huang, Y., Shen, X., Guo, Y., Tan, L., Dong, Q., Yu, J., & Initiative, A. D. N. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01476-7 · Cited by 64
Jackson, J., Rentz, D. M., Aghjayan, S. L., Buckley, R. F., Meneide, T.-F., Sperling, R. A., & Amariglio, R. E. (2017) · Age and Ageing · doi:10.1093/ageing/afx077 · Cited by 64
Self-citationGrober, E. H., Veroff, A. E., & Lipton, R. B. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.12.004 · Cited by 68
Caillaud, M. L., Hudon, C., Boller, B., Brambati, S. M., Duchesne, S., Lorrain, D., Gagnon, J., Maltezos, S., Mellah, S., Phillips, N. A., et al. (2019) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbz120 · Cited by 75
Geriatric Medicine and Gerontology
Zawada, E. T. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.77654 · Cited by 64
Firth, N. C., Primativo, S., Brotherhood, E., Young, A. L., Yong, K. X. X., Crutch, S. J., Alexander, D. C., & Oxtoby, N. P. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12083 · Cited by 65
Self-citationCacciamani, F., Houot, M., Gagliardi, G. P., Dubois, B., Sikkes, S. A. M., Sánchez‐Benavides, G., Denicolò, E., Molinuevo, J. L., Vannini, P., & Epelbaum, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.697234 · Cited by 63
Self-citationYıldırım, S., Nalbantoğlu, Ö. U., Bayraktar, A., Ercan, F. B., Gündoğdu, A., Velioğlu, H. A., Göl, M. F., Ekinci, A., Koç, F., Aslan-Gülpınar, E., et al. (2022) · mSystems · doi:10.1128/msystems.00004-22 · Cited by 62
Monfared, A. A. T., Phan, N. T. N., Pearson, I. V., Mauskopf, J., Cho, M., Zhang, Q., & Hampel, H. J. (2023) · Neurology and Therapy · doi:10.1007/s40120-023-00504-6 · Cited by 63
Self-citationAchour, I., Arel-Dubeau, A.-M., Renaud, J., Legrand, M., Attard, E., Germain, M., & Martinoli, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081293 · Cited by 64
The Emergence of a New Conceptual Framework for Alzheimer’s Disease
Dubois, B. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170536 · Cited by 62
Self-citationWang, M., Tang, G., Zhou, C., Guo, H., Hu, Z., Hu, Q., & Li, G. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110387 · Cited by 62
Recent Advances in Neuropsychological Test Interpretation for Clinical Practice
Kiselica, A. M., Karr, J. E., Mikula, C. M., Ranum, R. M., Benge, J. F., Medina, L. D., & Woods, S. P. (2023) · Neuropsychology Review · doi:10.1007/s11065-023-09596-1 · Cited by 64
Metabolic Syndrome and the Cellular Phase of Alzheimer's Disease
Pugazhenthi, S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.016 · Cited by 65
Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition
Stephen, R., Liu, Y., Ngandu, T., Rinne, J. O., Kemppainen, N. M., Parkkola, R. K., Laatikainen, T. K., Paajanen, T. I., Hänninen, T., Strandberg, T. E., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170092 · Cited by 62
Self-citationAl-Nuaimi, A. H. H., Jammeh, E., Sun, L., & Ifeachor, E. (2017) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2017.8037320 · Cited by 67
The Spatial-Temporal Ordering of Amyloid Pathology and Opportunities for PET Imaging
Fantoni, E., Collij, L. E., Alves, I. L., Buckley, C. J., & Farrar, G. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.235879 · Cited by 65
Behfar, Q., Behfar, S. K., von Reutern, B., Richter, N., Dronse, J., Fassbender, R. V., Fink, G. R., & Onur, O. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.576627 · Cited by 63
Measuring brain synaptic vesicle protein 2A with positron emission tomography and [ 18 F]UCB‐H
Bahri, M. A., Plenevaux, A., Aerts, J., Bastin, C., Becker, G., Mercier, J., Valade, A., Buchanan, T., Mestdagh, N., Ledoux, D., et al. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.08.004 · Cited by 61
Recent advances in research on Alzheimer's disease in China
Zhang, Y., Li, Y., & Ma, L. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.09.018 · Cited by 61
Gut microbiome alterations in preclinical Alzheimer’s disease
Jung, J. H., Kim, G., Byun, M. S., Lee, J. H., Yi, D., Park, H., & Lee, D. Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278276 · Cited by 63
From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology
Toader, C., Dobrin, N., Brehar, F.-M., Popa, C., Covache-Busuioc, R.-A., Glavan, L.-A., Costin, H. P., Bratu, B.-G., Corlatescu, A.-D., Popa, A. A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216119 · Cited by 63
Search for Alzheimer's Disease Biomarkers in Blood Cells: Hypotheses-Driven Approach
Wojsiat, J., Laskowska-Kaszub, K., Mietelska‐Porowska, A., & Wojda, U. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0041 · Cited by 61
Chatterjee, P., Goozee, K. G., Lim, C. K., JAMES, I. R., Shen, K., Jacobs, K. R., Sohrabi, H. R., Shah, T. M., Asih, P. R., Dave, P., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25968-7 · Cited by 60
Sekhon, H., Allali, G., Launay, C. P., Barden, J. M., Szturm, T. J., Liu-Ambrose, T. Y. L., Chester, V. L., Wong, C. H., & Beauchet, O. (2019) · Maturitas · doi:10.1016/j.maturitas.2019.02.006 · Cited by 63
Quantifying brain metabolism from FDG‐PET images into a probability of Alzheimer's dementia score
Yee, E., Popuri, K., Beg, M. F., & Initiative, T. A. D. N. (2019) · Human Brain Mapping · doi:10.1002/hbm.24783 · Cited by 61
Negahdary, M., & Heli, H. (2019) · Microchimica Acta · doi:10.1007/s00604-019-3903-x · Cited by 61
Watson, C. M., Dammer, E. B., Ping, L., Duong, D. M., Modeste, E. S., Carter, E. K., Johnson, E. C. B., Levey, A. I., Lah, J. J., Roberts, B. R., et al. (2023) · Scientific Data · doi:10.1038/s41597-023-02158-3 · Cited by 59
Akhtar, R. S., Licata, J. P., Luk, K. C., Shaw, L. M., Trojanowski, J. Q., & Lee, V. M. ‐. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14330 · Cited by 60
Ferrer, I., Andrés‐Benito, P., Ausín, K., Pamplona, R., del Río, J. A., Fernández‐Irigoyen, J., & Santamaría, E. (2021) · Brain Pathology · doi:10.1111/bpa.12996 · Cited by 61
Malkov, A., Popova, I., Ivanov, A., Jang, S.-S., Yoon, S. Y., Osypov, A., Huang, Y., Zilberter, Y., & Zilberter, M. (2021) · Communications Biology · doi:10.1038/s42003-021-02551-x · Cited by 59
Vergallo, A., Bun, R., Toschi, N., Baldacci, F., Zetterberg, H., Blennow, K., Cavedo, E., Lamari, F., Habert, M., Dubois, B., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.06.3053 · Cited by 59
Self-citationThe Role of Magnetoencephalography in the Early Stages of Alzheimer’s Disease
López‐Sanz, D., Serrano, N., & Maestú, F. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00572 · Cited by 60
Guennewig, B., Lim, J., Marshall, L. L., McCorkindale, A. N., Paasila, P. J., Patrick, E., Kril, J. J., Halliday, G. M., Cooper, A. A., & Sutherland, G. T. (2021) · Scientific Reports · doi:10.1038/s41598-021-83872-z · Cited by 59
Cholinergic white matter pathways along the Alzheimer's disease continuum
Němý, M., Dyrba, M., Brosseron, F., Büerger, K., Dechent, P., Dobisch, L., Ewers, M., Fließbach, K., Glanz, W., Göerß, D., et al. (2022) · Brain · doi:10.1093/brain/awac385 · Cited by 60
Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer's disease
Devanarayan, V., Doherty, T., Charil, A., Sachdev, P., Ye, Y., Murali, L. K., Llano, D. A., Zhou, J., Reyderman, L., Hampel, H. J., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14073 · Cited by 61
Self-citationJoie, R. L., Perrotin, A., Egret, S., Pasquier, F., Tomadesso, C., Mézenge, F., Desgranges, B., Sayette, V. D. L., & Chételat, G. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.12.005 · Cited by 64
Lu, K., Nicholas, J. M., Collins, J. D., James, S., Parker, T. D., Lane, C., Keshavan, A., Keuss, S. E., Buchanan, S. M., Murray‐Smith, H., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008534 · Cited by 59
Self-citationAlzheimer’s disease: a review on the current trends of the effective diagnosis and therapeutics
Manap, A. S. A., Almadodi, R., Sultana, S., Sebastian, M. G., Kavani, K. S., Lyenouq, V. E., & Shankar, A. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1429211 · Cited by 66
Subclinical Atherosclerosis and Brain Metabolism in Middle-Aged Individuals
Cortés‐Canteli, M., Gispert, J. D., Salvadó, G., Toribio‐Fernández, R., Tristão‐Pereira, C., Falcón, C., Oliva, B., Mendiguren, J. M., Fernández‐Friera, L., Sanz, J., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.12.027 · Cited by 57
Self-citationPredicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer’s Disease
Herring, W. L., Gould, I. G., Fillit, H. M., Lindgren, P., Forrestal, F., Thompson, R., & Pemberton-Ross, P. J. (2021) · Neurology and Therapy · doi:10.1007/s40120-021-00273-0 · Cited by 57
Valletta, M., Vetrano, D. L., Xia, X., Rizzuto, D., Roso‐Llorach, A., Calderón‐Larrañaga, A., Marengoni, A., Laukka, E. J., Canevelli, M., Bruno, G., et al. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13683 · Cited by 57
Hiller, A. J., & Ishii, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00471 · Cited by 59
Verberk, I. M. W., Hendriksen, H. M. A., van Harten, A. C., Wesselman, L. M. P., Verfaillie, S. C. J., van den Bosch, K. A., Slot, R. E. R., Prins, N. D., Scheltens, P., Teunissen, C. E., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.01.007 · Cited by 56
Self-citation
Metadata
- Authors
- Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., Broich, K., Cavedo, E., Crutch, S., Dartigues, J., Duyckaerts, C., Epelbaum, S., Frisoni, G. B., Gauthier, S., Genthon, R., Gouw, A. A., Habert, M., Holtzman, D. M., Kivipelto, M., Lista, S., Molinuevo, J., O'Bryant, S. E., Rabinovici, G. D., Rowe, C., Salloway, S., Schneider, L. S., Sperling, R., Teichmann, M., Carrillo, M. C., Cummings, J., Jack, C. R., & Proceedings of the Meeting of the International Working Group (IWG) and the American Alzheimer's Association on “The Preclinical State of AD”; July 23, 2. W. D.
- Affiliations
- Sorbonne Université (FR)
- University of British Columbia (CA)
- Amsterdam Neuroscience (NL)
- University of Southern California (US)
- Université Toulouse III - Paul Sabatier (FR)
- Institut du Cerveau (FR)
- Centre National de la Recherche Scientifique (FR)
- Institute for Integrative and Experimental Genomics (DE)
- Sahlgrenska University Hospital (SE)
- Federal Institute for Drugs and Medical Devices (DE)
- Centro San Giovanni di Dio Fatebenefratelli (IT)
- UCL Queen Square Institute of Neurology (GB)
- Université de Bordeaux (FR)
- University of Geneva (CH)
- Douglas Mental Health University Institute (CA)
- Fondation pour la Recherche sur Alzheimer Hôpital Pitié‐Salpêtrière Paris France
- Washington University in St. Louis (US)
- Karolinska University Hospital (SE)
- AXA Research Fund (FR)
- Alzheimer's Disease and Other Cognitive Disorders Unit, Hospital Clínic Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain
- Center for Alzheimer's & Neurodegenerative Disease Research University of North Texas Health Science Center TX USA
- University of California, San Francisco (US)
- The University of Melbourne (AU)
- Brown University (US)
- Brigham and Women's Hospital (US)
- The Alzheimer's Association Division of Medical & Scientific Relations Chicago USA
- Cleveland Clinic (US)
- Department of Radiology Mayo Clinic Rochester MN USA
- Corresponding author
- Dubois, Bruno
- ORCID
- Dubois, Bruno
- Hampel, Harald
- Feldman, Howard H.
- Scheltens, Philip
- Andrieu, Sandrine
- Bakardjian, Hovagim
- Benali, Habib
- Bertram, Lars
- Blennow, Kaj
- Broich, Karl
- Cavedo, Enrica
- Crutch, Sebastian
- Dartigues, Jean‐François
- Duyckaerts, Charles
- Epelbaum, Stéphane
- Frisoni, Giovanni B.
- Gauthier, Serge
- Gouw, Alida A.
- Habert, Marie‐Odile
- Holtzman, David M.
- Kivipelto, Miia
- Lista, Simone
- Rabinovici, Gil D.
- Rowe, Christopher
- Salloway, Stephen
- Schneider, Lon S.
- Sperling, Reisa
- Teichmann, Marc
- Cummings, Jeffrey
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2016-03
- Volume
- 12
- Issue
- 3
- Pages
- 292-323
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- PMC
- PMC6417794
- OpenAlex
- W2309442902
- Cited by
- 1,925
- References
- 298
- Citations by year
- 2026: 115 · 2025: 176 · 2024: 244 · 2023: 245 · 2022: 247 · 2021: 244 · 2020: 176 · 2019: 157 · 2018: 161 · 2017: 112 · 2016: 47
- FWCI
- 22.78
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Alzheimer s & Dementia (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- AXA Research Fund
- National Institute on Aging
- Alzheimer's Association
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- preclinical Alzheimer's disease, Alzheimer's disease continuum
- MeSH terms
- Alzheimer Disease, Animals, Brain, Humans, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
